103 related articles for article (PubMed ID: 3871758)
1. Cellular distribution of a human I-A-like (DS/DC) antigen on normal and neoplastic lymphoid cells.
Marti GE; Nadler LM; Chused TM; Tosato G; Blaese RM; Kindt TJ
Hum Immunol; 1985 Jan; 12(1):23-35. PubMed ID: 3871758
[TBL] [Abstract][Full Text] [Related]
2. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.
Chen YX; Evans RL; Pollack MS; Lanier LL; Phillips JH; Rousso C; Warner NL; Brodsky FM
Hum Immunol; 1984 Aug; 10(4):221-35. PubMed ID: 6332101
[TBL] [Abstract][Full Text] [Related]
3. A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA-D/DR antigens.
Marti GE; Kuo MC; Shaw S; Chang CC; Demars R; Sogn JA; Coligan JE; Kindt TJ
J Exp Med; 1983 Dec; 158(6):1924-37. PubMed ID: 6606012
[TBL] [Abstract][Full Text] [Related]
4. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
Horibe K; Knowles RW; Dupont B
Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of a unique monoclonal antibody against human B cells (33.2.1).
Honda M; Steinberg AD
Cell Immunol; 1985 Jun; 93(1):105-23. PubMed ID: 2581708
[TBL] [Abstract][Full Text] [Related]
6. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
[TBL] [Abstract][Full Text] [Related]
7. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
8. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
9. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
Zhong G; Reis e Sousa C; Germain RN
J Exp Med; 1997 Aug; 186(5):673-82. PubMed ID: 9271583
[TBL] [Abstract][Full Text] [Related]
10. HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1985 Jun; 15(6):620-6. PubMed ID: 3159585
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.
Hock BD; Starling GC; Daniel PB; Hart DN
Immunology; 1994 Dec; 83(4):573-81. PubMed ID: 7875738
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR antigens on lymphoid cells differ from those on myeloid cells.
Torok-Storb B; Nepom GT; Nepom BS; Hansen JA
Nature; 1983 Oct 6-12; 305(5934):541-3. PubMed ID: 6194439
[TBL] [Abstract][Full Text] [Related]
13. Cell surface antigens expressed by subsets of pre-B cells and B cells.
McKearn JP; Baum C; Davie JM
J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
[TBL] [Abstract][Full Text] [Related]
14. Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants.
Ewert DL; Munchus MS; Chen CL; Cooper MD
J Immunol; 1984 May; 132(5):2524-30. PubMed ID: 6201548
[TBL] [Abstract][Full Text] [Related]
15. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.
Fuggle SV; Kirkley J; Ting A; Morris PJ
Immunogenetics; 1983; 18(4):415-28. PubMed ID: 6195109
[TBL] [Abstract][Full Text] [Related]
17. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
18. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
19. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
20. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
